jaundice of the newborn
Conditions
Interventions
Experimental group (Full-term):probiotics
Control group (Full-term):placebo
Experimental group (premature):probiotics
Control group (premature):placebo
Sponsors
Northwest Women and Children's Hospital
Eligibility
Sex/Gender
All
Age
1 Days to 30 Days
Inclusion criteria
Inclusion criteria: (1) Neonates with jaundice requiring blue light treatment (2) Gestational age 34-41 weeks (3) Birth weight is more than 2000g and less than 4000g
Exclusion criteria
Exclusion criteria: (1) Neonatal hypothyroidism (2) Trisomy syndrome (3) Maternal ABO incompatibility (4) Gastrointestinal diseases (5) Erythrocyte glucose-6-phosphate dehydrogenase (G-6-PD) deficiency (6) Hemangioma (7) Cranial hematoma or hemorrhage (8) Severe asphyxia (Phase III) (9) Fetal chromosomal abnormality (10) Cyanotic congenital heart disease (11) Omphalocele (12) Premature septicemia (13) Liver failure (14) Newborn hepatitis, biliary atresia, genetic metabolic disorder and other serious primary diseases with direct increase of bilirubin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum bilirubin; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intestinal flora; | — |
Countries
China
Contacts
Public ContactYu Xiping
Northwest Women and Children's Hospital
Outcome results
None listed